Description
About Ossium
Ossium’s mission is to improve the health, vitality, and longevity of human beings through bioengineering. We develop, manufacture, and bank cell therapy products that apply the power of stem cell science to revolutionize treatment for patients with blood, immune, and orthopedic diseases. At Ossium, we empower our employees, maintain the highest standards of operational excellence, and are a force for good.
About the Job
We’re hiring a contract position that will be responsible for overseeing and leading the commercial contracting, as well as coordinating trade agreement execution efforts for our growing cell therapy organization. This role will focus specifically on contracting between Ossium and transplant centers, driving efficient execution of agreements, accelerating time to contract, and strengthening key customer relationships.
You will be responsible for executing the contracting process by managing a high volume of active agreements with transplant centers. You will engage with transplant program administrators, hospital contracting teams, finance, and legal stakeholders to drive contract redlining, negotiation, and progression toward final agreement. The role includes managing iterative contract revisions, facilitating alignment across stakeholders, and ensuring contracts reflect agreed-upon commercial and operational terms. The Contracting Manager actively identifies and resolves bottlenecks, maintains momentum across multiple parallel agreements, and supports onboarding of new transplant centers through completion of contracting.
This is a contract role that may be performed remotely from any location in the United States.
Required Qualifications
- Bachelor’s degree (Business, Life Sciences, or related field preferred)
- 3–7 years of experience in healthcare, biotech, or pharma contracting, specifically within transplant, cell therapy (e.g., CAR-T), or hospital-based agreements
- Proven track record of independently managing contract redlining, negotiation cycles, and execution to near-final agreement
- Strong understanding of hospital contracting processes and stakeholder dynamics
- Experience working directly with community, private, and academic transplant centers preferred
- Excellent communication, negotiation, and stakeholder management skills
- Strong attention to detail and ability to manage multiple contracts simultaneously
- Ability to operate with a high level of organization and excellent time management in a dynamic startup environment
- Excellent written and oral communication skills
Preferred Qualification
- Experience in CAR-T, transplant, or other complex hospital-based contracting environments
- Familiarity with trade agreements, MSAs, and service agreements in healthcare settings
Key Responsibilities
- Lead and execute commercial contracting and trade agreement activities between Ossium and transplant centers
- Manage end-to-end contract lifecycle, including drafting, redlining, negotiation, and progression to near-final agreement
- Serve as the primary point of contact for transplant centers on all contracting-related matters
- Drive timely contract execution by proactively managing follow-ups, resolving comments, and removing bottlenecks
- Build and maintain strong relationships with transplant program administrators, hospital contracting teams, finance, and legal stakeholders
- Collaborate with internal teams including Commercial, Legal, Finance, Operations, and Medical Affairs to align on contract terms and resolve issues
- Ensure consistency with company templates while accommodating necessary center-specific modifications
- Track contract status, maintain documentation, and provide visibility into pipeline and progress
- Ensure compliance with company policies, regulatory standards, and industry guidelines
Ossium provides equal employment opportunities (EEO) to all employees and applicants for employment without regard to race, color, religion, sex, national origin, age, disability, sexual orientation, gender identity or gender expression.
Similar jobs
Est. 120,000 USD
About Ossium Ossium’s mission is to improve the health, vitality, and longevity of human beings through bioengineering. We develop, manufacture, and bank cell therapy products that apply the power of stem cell science to…
Est. 120,000 USD
About Ossium Ossium’s mission is to improve the health, vitality, and longevity of human beings through bioengineering. We develop, manufacture, and bank cell therapy products that apply the power of stem cell science to…
Est. 120,000 USD
About Ossium Ossium’s mission is to improve the health, vitality, and longevity of human beings through bioengineering. We develop, manufacture, and bank cell therapy products that apply the power of stem cell science to…
Est. 140,000 USD
About Ossium Ossium’s mission is to improve the health, vitality, and longevity of human beings through bioengineering. We develop, manufacture, and bank cell therapy products that apply the power of stem cell science to…
Est. 140,000 USD
About Ossium Ossium’s mission is to improve the health, vitality, and longevity of human beings through bioengineering. We develop, manufacture, and bank cell therapy products that apply the power of stem cell science to…
Est. 347,615 USD
About Ossium Ossium’s mission is to improve the health, vitality, and longevity of human beings through bioengineering. We develop, manufacture, and bank cell therapy products that apply the power of stem cell science to…
Est. 55,000 USD
About Ossium Ossium’s mission is to improve the health, vitality, and longevity of human beings through bioengineering. We develop, manufacture, and bank cell therapy products that apply the power of stem cell science to…
Est. 190,000 USD
MyOme’s mission is to provide clinically actionable genetic information to patients throughout their lives. We combine clinical-grade whole genome sequencing, advanced AI methods for genome interpretation, and seamless d…
Est. 209,500 USD
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress…
Est. 120,000 USD
Isomorphic Labs is applying frontier AI to help unlock deeper scientific insights, faster breakthroughs, and life-changing medicines with an ambition to solve all disease. The future is coming. A future enabled and enric…
Est. 87,912 USD
Company Overview Immunome is a clinical-stage targeted oncology company committed to developing first-in-class and best-in-class targeted cancer therapies. We are advancing an innovative portfolio of therapeutics, suppor…
Est. 102,500 USD
Who We Are: Cogent Biosciences is a publicly traded biotechnology company focused on developing novel precision therapies to treat a broad range of patients with unmet medical needs. Cogent’s lead program, bezuclastinib,…
Est. 192,500 USD
Olema Oncology is a clinical-stage biopharmaceutical company committed to transforming the standard of care and improving outcomes for patients living with breast cancer and beyond. It’s an exciting time to be part of Te…
Est. 192,500 USD
Olema Oncology is a clinical-stage biopharmaceutical company committed to transforming the standard of care and improving outcomes for patients living with breast cancer and beyond. It’s an exciting time to be part of Te…
Est. 93,120 USD
Company Overview Immunome is a clinical-stage targeted oncology company committed to developing first-in-class and best-in-class targeted cancer therapies. We are advancing an innovative portfolio of therapeutics, suppor…
Est. 210,000 USD
At Adaptive, we’re Powering the Age of Immune Medicine. Our goal is to harness the power of the adaptive immune system to transform the way diseases are diagnosed and treated. As an Adapter, you’ll have the opportunity t…
Est. 285,000 USD
Olema Oncology is a clinical-stage biopharmaceutical company committed to transforming the standard of care and improving outcomes for patients living with breast cancer and beyond. It’s an exciting time to be part of Te…
Est. 207,000 USD
Vir Biotechnology, Inc. is a clinical-stage biopharmaceutical company focused on powering the immune system to transform lives by discovering and developing medicines for serious infectious diseases and cancer. Its clini…
Est. 285,000 USD
Olema Oncology is a clinical-stage biopharmaceutical company committed to transforming the standard of care and improving outcomes for patients living with breast cancer and beyond. It’s an exciting time to be part of Te…
Est. 215,000 USD
At Adaptive, we’re Powering the Age of Immune Medicine. Our goal is to harness the power of the adaptive immune system to transform the way diseases are diagnosed and treated. As an Adapter, you’ll have the opportunity t…
Est. 200,000 USD
Olema Oncology is a clinical-stage biopharmaceutical company committed to transforming the standard of care and improving outcomes for patients living with breast cancer and beyond. It’s an exciting time to be part of Te…
Est. 170,000 USD
Rapidly Growing Life Sciences Technology Company Ultima Genomics is a rapidly growing company that is developing ground-breaking genomics technologies. Our mission is to continuously drive the scale of genomic informatio…
Est. 200,000 USD
Olema Oncology is a clinical-stage biopharmaceutical company committed to transforming the standard of care and improving outcomes for patients living with breast cancer and beyond. It’s an exciting time to be part of Te…
Est. 205,950 USD
Company: At Annexon Biosciences we are a biopharmaceutical company advancing a late-stage clinical platform of novel therapies for people living with devastating classical complement-mediated neuroinflammatory diseases o…
Est. 140,000 USD
Olema Oncology is a clinical-stage biopharmaceutical company committed to transforming the standard of care and improving outcomes for patients living with breast cancer and beyond. It’s an exciting time to be part of Te…
Est. 262,500 USD
Olema Oncology is a clinical-stage biopharmaceutical company committed to transforming the standard of care and improving outcomes for patients living with breast cancer and beyond. It’s an exciting time to be part of Te…
Est. 140,000 USD
Olema Oncology is a clinical-stage biopharmaceutical company committed to transforming the standard of care and improving outcomes for patients living with breast cancer and beyond. It’s an exciting time to be part of Te…
Est. 150,000 USD
Iovance Biotherapeutics aims to be the global leader in innovating, developing and delivering tumor infiltrating lymphocyte (TIL) therapy for people with cancer. We are pioneering a transformational approach to treating…
Est. 135,000 USD
Olema Oncology is a clinical-stage biopharmaceutical company committed to transforming the standard of care and improving outcomes for patients living with breast cancer and beyond. It’s an exciting time to be part of Te…
Est. 235,000 USD
Olema Oncology is a clinical-stage biopharmaceutical company committed to transforming the standard of care and improving outcomes for patients living with breast cancer and beyond. It’s an exciting time to be part of Te…